Literature DB >> 8444992

Evaluation of the revised Ontario Child Health Study scales.

M H Boyle1, D R Offord, Y Racine, J E Fleming, P Szatmari, M Sanford.   

Abstract

This article describes the development and evaluation of the revised Ontario Child Health Study (OCHS) scales to measure conduct disorder, oppositional disorder, attention-deficit hyperactivity disorder, overanxious disorder, separation anxiety and depression based on DSM-III-R symptom criteria. Problem checklist assessments were obtained from parents and teachers of children aged 6-16 and youths aged 12-16 drawn from: (1) a general population sample (N = 1751); and (2) a mental health clinic sample (N = 1027) in the same industrialized, urban setting. Evaluation of the revised OCHS scales indicates that they possess adequate psychometric properties and provide an efficient means to obtain measurements of childhood psychiatric disorder, in general population studies, that correspond to DSM-III-R classification of disorder.

Entities:  

Mesh:

Year:  1993        PMID: 8444992     DOI: 10.1111/j.1469-7610.1993.tb00979.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  62 in total

1.  Genetic variation in the KIAA0319 5' region as a possible contributor to dyslexia.

Authors:  Adrienne Elbert; Maureen W Lovett; Tasha Cate-Carter; Ashley Pitch; Elizabeth N Kerr; Cathy L Barr
Journal:  Behav Genet       Date:  2011-01-05       Impact factor: 2.805

2.  Behavioral and emotional symptoms of post-institutionalized children in middle childhood.

Authors:  Kristen L Wiik; Michelle M Loman; Mark J Van Ryzin; Jeffrey M Armstrong; Marilyn J Essex; Seth D Pollak; Megan R Gunnar
Journal:  J Child Psychol Psychiatry       Date:  2011-01       Impact factor: 8.982

3.  Frontal electroencephalogram asymmetry, salivary cortisol, and internalizing behavior problems in young adults who were born at extremely low birth weight.

Authors:  Louis A Schmidt; Vladimir Miskovic; Michael Boyle; Saroj Saigal
Journal:  Child Dev       Date:  2010 Jan-Feb

4.  Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C.

Authors:  C L Barr; K Wigg; G Zai; W Roberts; M Malone; R Schachar; R Tannock; J L Kennedy
Journal:  Mol Psychiatry       Date:  2001-05       Impact factor: 15.992

5.  Association of reading disabilities with regions marked by acetylated H3 histones in KIAA0319.

Authors:  Jillian M Couto; Izzy Livne-Bar; Katherine Huang; Zhaodong Xu; Tasha Cate-Carter; Yu Feng; Karen Wigg; Tom Humphries; Rosemary Tannock; Elizabeth N Kerr; Maureen W Lovett; Rod Bremner; Cathy L Barr
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

6.  Cyberbullying Victimization and Adolescent Mental Health: Evidence of Differential Effects by Sex and Mental Health Problem Type.

Authors:  Soyeon Kim; Scott R Colwell; Anna Kata; Michael H Boyle; Katholiki Georgiades
Journal:  J Youth Adolesc       Date:  2017-04-22

7.  Exposure to maternal depressive symptoms in childhood and suicide-related thoughts and attempts in Canadian youth: test of effect-modifying factors.

Authors:  Sarah Margaret Goodday; Susan Bondy; Rinku Sutradhar; Hilary K Brown; Anne Rhodes
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-10-24       Impact factor: 4.328

8.  The impact of chronic physical illness, maternal depressive symptoms, family functioning, and self-esteem on symptoms of anxiety and depression in children.

Authors:  Mark A Ferro; Michael H Boyle
Journal:  J Abnorm Child Psychol       Date:  2015-01

9.  The brain-derived neurotrophic factor Val66Met polymorphism moderates early deprivation effects on attention problems.

Authors:  Megan R Gunnar; Jennifer A Wenner; Kathleen M Thomas; Charles E Glatt; Morgan C McKenna; Andrew G Clark
Journal:  Dev Psychopathol       Date:  2012-11

10.  Convergent validity of K-SADS-PL by comparison with CBCL in a Portuguese speaking outpatient population.

Authors:  Heloisa H A Brasil; Isabel A Bordin
Journal:  BMC Psychiatry       Date:  2010-10-19       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.